12.94

0.94% 0.12

Oculis Holding Ag (OCS)

Overview News Price History Discussions Forecast

Oculis Holding Ag stock is traded at $12.94, with a volume of 125.38K. It is up +0.94% in the last 24 hours and up +0.08% over the past month. Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Previous Close:

$12.82

Open:

$12.84

24h Volume:

125.38K

Relative Volume:

0.20

Market Cap:

$718.53M

Revenue:

Net Income/Loss:

$-117.99M

P/E Ratio:

-6.0476

EPS:

-2.1397

Net Cash Flow:

$-79.92M

1W Performance:

+2.05%

1M Performance:

+0.08%

6M Performance:

-54.58%

1Y Performance:

-27.30%

1-Day Range:

$12.52

$13.09

1-Week Range:

$12.31

$13.25

52-Week Range:

$10.52

$34.48

Oculis Holding Ag Stock (OCS) Company Profile

Name

Oculis Holding Ag

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-08-20

Latest SEC Filings

OCS's Discussions on Twitter

Compare OCS vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OCS Oculis Holding Ag	12.94	715.76M	0	-117.99M	-79.92M	-2.1397
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Oculis Holding Ag Stock (OCS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-19-25	Initiated	JP Morgan	Overweight
Aug-27-25	Initiated	Needham	Buy
Dec-05-23	Initiated	Chardan Capital Markets	Buy
Oct-05-23	Initiated	Stifel	Buy
Jun-14-23	Initiated	BofA Securities	Buy
Jun-12-23	Initiated	H.C. Wainwright	Buy
Jun-08-23	Initiated	Robert W. Baird	Outperform
May-10-23	Initiated	Pareto	Buy
Apr-28-23	Initiated	Wedbush	Outperform

View All

Oculis Holding Ag Stock (OCS) Latest News

Aug 14, 2026

The Technical Signals Behind (OCS) That Institutions Follow - Stock Traders Daily

Aug 14, 2026

Four Oculis directors' restricted stock units vest in Aug. 13 notifications - Stock Titan

Aug 14, 2026

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewswire

Aug 14, 2026

Oculis (NASDAQ:OCS) Price Target Cut to $20.00 by Analysts at JPMorgan Chase & Co. - MarketBeat

Aug 14, 2026

Does Oculis Holding AG (OCS) Have the Potential to Rally 187.83% as Wall Street Analysts Expect? - Zacks Investment Research

Aug 14, 2026

Stifel reiterates Buy rating on Oculis stock, $40 target By Investing.com - Investing.com South Africa

Aug 14, 2026

Stifel reiterates Buy rating on Oculis stock, $40 target - Investing.com

Aug 14, 2026

Aug 12, 2026

Oculis buys out privosegtor’s global rights from Accure - Glance by Eyes On Eyecare

Aug 12, 2026

HC Wainwright Has Negative Estimate for Oculis Q3 Earnings - MarketBeat

Aug 12, 2026

Aug 11, 2026

Oculis rebuilds pipeline with Privosegtor buy from Accure - AllSci

Aug 11, 2026